XML 13 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Common Stock [Member]
Common Stock Be Issued [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 600 $ 336,000 $ 58,151,817 $ 4,870 $ (62,229,405) $ (3,736,118)
Beginning balance, shares at Dec. 31, 2021 6,000,000          
Stock issued for conversion of non-redeemable convertible notes $ 101 684,899 685,000
Stock issued for conversion of non-redeemable convertible notes, shares 1,010,000          
Foreign exchange loss (1,183) (1,183)
Net loss (1,353,597) (1,353,597)
Ending balance, value at Mar. 31, 2022 $ 701 336,000 58,836,716 3,687 (63,583,002) (4,405,898)
Ending balance, shares at Mar. 31, 2022 7,010,000          
Beginning balance, value at Dec. 31, 2022 $ 13,742 336,000 78,895,425 39,141 (83,922,516) (4,638,208)
Beginning balance, shares at Dec. 31, 2022 137,402,624          
Stock issued for conversion of non-redeemable convertible notes $ 4,150 117,550 121,700
Stock issued for conversion of non-redeemable convertible notes, shares 41,500,000          
Stock issued for settlement of debt - related party $ 732 274,061 274,793
Stock issued for settlement of debt - related party, shares 7,323,924          
Stock issued for the conversion of Series B convertible preferred stock $ 700 69,161 69,861
Stock issued for the conversion of Series B Stock, shares 7,000,000          
Foreign exchange loss (7,088) (7,088)
Net loss (505,484) (505,484)
Ending balance, value at Mar. 31, 2023 $ 19,324 $ 336,000 $ 79,356,197 $ 32,053 $ (84,428,000) $ (4,684,426)
Ending balance, shares at Mar. 31, 2023 193,226,548